Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lee MW et al. - Multitargeted kinase inhibitors are associated with a significant risk of various cutaneous adverse events. HFSR is the commonest and most serious cutaneous toxicity in patients treated with these drugs.


Today in Clinical Pharmacology...keeping you current

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

A practical approach to using methotrexate
Dermatology in Practice, 10/09/09

Ustekinumab for the treatment of plaque psoriasis
Expert Review of Dermatology, 10/13/09

Today in Dermatologic Oncology...keeping you current

A practical approach to using methotrexate
Dermatology in Practice, 10/09/09

Melanoma Thickness Trends in the United States, 1988-2006
Journal of Investigative Dermatology, 10/19/09

Childhood melanoma
Clinics in Dermatology, 11/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address